What is the Best Measure of Daytime Sleepiness in Adults With Heart Failure? by Riegel, Barbara et al.
University of Pennsylvania
ScholarlyCommons
School of Nursing Departmental Papers School of Nursing
5-2013
What is the Best Measure of Daytime Sleepiness in
Adults With Heart Failure?
Barbara Riegel
University of Pennsylvania, briegel@nursing.upenn.edu
Alexandra L. Hanlon
Xuemei Zhang
Desiree Fleck
Steven L. Sayers
See next page for additional authors
Follow this and additional works at: http://repository.upenn.edu/nrs
Part of the Cardiology Commons, and the Cardiovascular Diseases Commons
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/nrs/30
For more information, please contact repository@pobox.upenn.edu.
Recommended Citation
Riegel, B., Hanlon, A. L., Zhang, X., Fleck, D., Sayers, S. L., Goldberg, L. R., & Weintraub, W. S. (2013). What is the Best Measure of
Daytime Sleepiness in Adults With Heart Failure?. Journal of the American Association of Nurse Practitioners, 25 (5), 272-279.
http://dx.doi.org/10.1111/j.1745-7599.2012.00784.x
What is the Best Measure of Daytime Sleepiness in Adults With Heart
Failure?
Abstract
Purpose
To identify the best screening measure of daytime sleepiness in adults with heart failure (HF).
Data sources
A total of 280 adults with HF completed the Epworth Sleepiness Scale, the Stanford Sleepiness Scale, and a
single Likert item measuring daytime sleepiness. The sensitivity and specificity of these self-report measures
were assessed in relation to a measure of daytime dysfunction from poor sleep quality.
Conclusions
Only 16% of the sample reported significant daytime dysfunction because of poor sleep quality. Those
reporting daytime dysfunction were likely to be younger (p < .001), to be unmarried (p = .002), to have New
York Heart Association (NYHA) functional class IV HF (p = .015), and to report low income (p = .006) and
fewer hours of sleep (p = .015). The measure of daytime sleepiness that was most sensitive to daytime
dysfunction was a single Likert item measured on a 10-point (1–10) scale. Patients with a score ≥4 were 2.4
times more likely to have daytime dysfunction than those with a score <4.
Implications for practice
Complaints of daytime dysfunction because of poor sleep are not common in adults with HF. Routine use of a
single question about daytime sleepiness can help nurse practitioners to identify those HF patients with
significant sleep issues that may require further screening.
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Abstract
Purpose—To identify the best screening measure of daytime sleepiness in adults with heart
failure (HF).
Data sources—280 adults with HF completed the Epworth Sleepiness Scale, the Stanford
Sleepiness Scale, and a single Likert item measuring daytime sleepiness. The sensitivity and
specificity of these self-report measures were assessed in relation to a measure of daytime
dysfunction from poor sleep quality.
Conclusions—Only 16% of the sample reported significant daytime dysfunction due to poor
sleep quality. Those reporting daytime dysfunction were likely to be younger (p<0.001), to be
unmarried (p=0.002), to have New York Heart Association (NYHA) functional class IV HF
(p=0.015), and to report low income (p=0.006) and fewer hours of sleep (p=0.015). The measure
of daytime sleepiness that was most sensitive to daytime dysfunction was a single Likert item
measured on a 10-point (1–10) scale. Patients with a score ≥ 4 were 2.4 times more likely to have
daytime dysfunction than those with a score <4.
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Implications for practice—Complaints of daytime dysfunction due to poor sleep are not
common in adults with HF. Routine use of a single question about daytime sleepiness can help
nurse practitioners to identify those HF patients with significant sleep issues that may require
further screening.
Sleep disordered breathing (SDB) is extremely common in adults with heart failure (HF). In
a recent prevalence study, 61% of HF patients had central or obstructive sleep apnea
(MacDonald, Fang, Pittman, White, & Malhotra, 2008). Yet, referral for polysomnography
is not routine, even in specialty HF settings (Riegel, Moser, Powell, Rector, & Havranek,
2006). Identification and treatment of SDB is imperative because an untreated sleep disorder
amplifies the strain on the heart with increased respiratory effort, hypoxia, and sympathetic
stimulation (Valdivia-Arenas, Powers, & Khayat, 2009). Persons with SDB are at increased
risk for myocardial infarction, stroke, arrhythmia, and probably early mortality (Selim, Won,
& Yaggi, 2010). Treatment of SDB may improve ejection fraction and outcomes for patients
with systolic HF and decrease pulmonary artery pressures for those with preserved ejection
fraction (Oldenburg et al., 2009).
In the general population, people with SDB are typically sleepy during the day and a
complaint of excessive daytime sleepiness is the symptom that stimulates a referral for
testing. Yet, daytime sleepiness is rarely pronounced in HF patients with SDB (Javaheri, et
al, 1998; Kaneko et al., 2003; Sin et al., 1999). Therefore, a sensitive, accurate, and easy-to-
administer screening method is needed to identify patients who may have SDB in order to
more quickly and efficiently address this dangerous comorbidity. The purpose of this study
was to test the sensitivity and specificity of three simple screening measures of daytime
sleepiness in adults with HF.
Daytime sleepiness is defined as difficulty maintaining a desired level of wakefulness
(Young, 2004). Individuals with excessive daytime sleepiness experience a feeling of being
drowsy with a tendency to actually fall asleep or nap, known as sleep propensity (Laffont et
al., 2002). There is general agreement that sleep propensity reflects the interaction of
homeostatic mechanisms and circadian rhythm (Achermann, 2004; Achermann & Borbely,
1994). The homeostatic mechanisms regulate sleep intensity, while the circadian clock
regulates the timing of sleep. Others have proposed that sleep propensity depends on the
relative strength of the sleep and wake drives (Edgar, Dement, & Fuller, 1993). The sleep
drive is the mechanism that tells us of the need for sleep while the wake drive reflects
chronobiological and environmental factors such as physical activity, which stimulate
arousal (Cluydts, De Valck, Verstraeten, & Theys, 2002). In adults with SDB, sleep
intensity and continuity are interrupted by repeated episodes when breathing stops or is
markedly reduced, which cause nighttime arousals and daytime sleep propensity (Banno &
Kryger, 2007).
Measures of Sleepiness
A variety of measures are available for the assessment of excessive daytime sleepiness.
Cluydts et al (2002) divided these measures into behavioral measures, subjective rating
scales, and electrophysiological measures. Behavioral measures include performance tests
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such as the psychomotor vigilance task (PVT). The PVT is a sensitive measure of lapses in
attention in response to daytime sleepiness (Dinges et al., 1997). Subjective rating scales
reflect acute or global sleepiness. Two examples of subjective rating scales are the Stanford
Sleepiness Scale (SSS) and the Epworth Sleepiness Scale (ESS) (Hoddes, Zarcone, Smythe,
Phillips, & Dement, 1973). The SSS measures sleepiness at a particular moment while the
ESS measures global or typical sleepiness (Johns, 1992). Electrophysiological measures
include tests such as polysomnography, pupillometry, and the Multiple Sleep Latency Test.
When sensitivity and specificity of the Multiple Sleep Latency Test, the maintenance of
wakefulness test, and the ESS were compared, the ESS was the most discriminating test
(Johns, 2000). These measures vary greatly in cost, equipment, and training requirements.
As the goal of this study was to identify a measure of daytime sleepiness that is sensitive to
daytime dysfunction in adults with HF, self-report measures that can be used to screen
patients in an office setting were preferentially tested. We assessed the ability of three such
measures of daytime sleepiness to identify sufficiently poor sleep quality to cause
complaints of daytime dysfunction in adults with HF. The measure tested in addition to the
ESS and the SSS was a simple Likert item assessing sleepiness. Poor sleep quality was
measured with the daytime dysfunction subscale of the Pittsburgh Sleep Quality Index
(Buysse, 1989). A measure of daytime dysfunction due to poor sleep was chosen because
others have shown that SDB can cause daytime dysfunction even in those individuals who
do not perceive being sleepy (Verstraeten & Cluydts, 2004).
Methods
A sample of 280 adults with HF was enrolled from 3 sites in Philadelphia Pennsylvania and
Newark Delaware as part of a larger study of the impact of sleepiness on HF self-care.
Institutional review board approval was obtained from each institution and every subject
provided informed consent. Data for the current descriptive study were collected by research
assistants at enrollment, which took place during home visits. Further details of this study
have been published previously (Riegel et al., in press).
Study Population
All participants had chronic (systolic or diastolic) symptomatic HF confirmed based on
echocardiographic and clinical evidence and were: 1) able to perform tests (e.g., sufficient
visual and hearing acuity, able to speak and read English); and 2) living in a community
(noninstitutional) setting. We excluded those with major depression to avoid issues of
sleepiness caused by depression. Anyone noted in the medical record to have a major
depressive illness were excluded. We also screened potential participants with the 9-item
Patient Health Questionnaire (PHQ-9) (Kroenke, Spitzer, & Williams, 2001); anyone
reporting 5 or more of the 9 symptoms more than half the days in the past 2 weeks (1 of the
symptoms had to be depressed mood or anhedonia) was excluded. Anyone with a positive
response to the item asking about suicidal ideation or with evidence of major depression was
strongly encouraged to seek care and the provider was notified. We also excluded
individuals with significant cognitive impairment by history or on testing with the
Telephone Interview for Cognition Screening (TICS); anyone with a score < 24 (significant
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cognitive impairment) was excluded (Brandt & Folstein, 2003). Individuals with an
imminently terminal illness, plans to move out of the area, a history of drug or alcohol abuse
within the prior year, night shift workers, and those on renal dialysis were excluded. In total,
333 eligible individuals were identified and 280 were enrolled.
Measurement
Sleep dysfunction was assessed with the daytime dysfunction subscale of the Pittsburgh
Sleep Quality Index (PSQI), a subjective rating scale (Buysse, 1989). The subscale items ask
about staying awake and maintaining enough enthusiasm to get things done during the day.
The two items are scored 0 (not in the past month) to 3 (three or more times a week),
summed and then compressed into a subscale score ranging from 0–3; a higher score
indicates more daytime dysfunction. When the full PSQI score is used, a score > 5 has a
sensitivity of 89.6% and a specificity of 86.5% in distinguishing good and poor sleepers. In
this study, the score on PSQI daytime dysfunction subscale was dichotomized at a cut-point
of 2 (0/1 versus 2/3).
Epworth Sleepiness Scale (ESS)—Respondents rated the likelihood of falling asleep in
8 soporific situations using a 4-point scale ranging from never dozing (0) to high chance of
dozing (3) (Johns, 1993). Test-retest reliability (r = 0.82) and internal consistency (α = 0.88)
have been established in addition to its single factor structure (Johns, 2000). Scores are
summed, with higher scores indicating greater sleepiness, or categorized as sleepy (≥11) or
not sleepy (<11). At this cut-point of 11, the ESS had a sensitivity of 93.5% and a specificity
of 100% for distinguishing pathological from normal sleepiness in a sample drawn from
sleep disorder centers (Maislin et al., 1995). This cut-point on the ESS, however, may not
adequately detect excessive daytime sleepiness in adults with HF (Javaheri, et al., 1998;
Kaneko, et al., 2003; Sin, et al., 1999). So, in addition to a cut-point of 11 (sleepy ≥ 11 or
not sleepy < 11), we tested a cut-point of 6 (sleepy ≥ 6 or not sleepy < 6) on the advice of
the instrument author (Murray Johns, personal communication, 2006). This lower cut-point
allowed us to have a higher index of suspicion for HF patients who are known to have less
sleepiness than other patient groups. Since the instrument itself was not changed, this
different cut-point did not affect the reliability and validity of the measure.
Stanford Sleepiness Scale (SSS)—The SSS is one of the oldest subjective sleepiness
scales still in use today (Hoddes, Zarcone, Smythe, Phillips, & Dement, 1973). Subjects
evaluate their current degree of sleepiness from 1 to 7 with 1 equivalent to feeling vital,
alert, or wide-awake and 7 equivalent to feeling that sleep onset is soon. The SSS is said to
be sensitive to both sleep deprivation and time of day (Babkoff, Caspy, & Mikulincer, 1991;
Johnson, Freeman, Spinweber, & Gomez, 1991). The SSS was shown to be sensitive to
deficits in alertness following partial sleep deprivation, although it did not predict individual
performance on vigilance tests (Herscotch & Broughton, 1981). In this study we tested a
cut-point of 4 on the SSS (sleepy ≥ 4 or not sleepy < 4), which corresponds to “a little
foggy; not at peak; let down”.
Likert Item—Rating scales are commonly used to measure attitudes and perceptions. The
sensitivity of such items is determined by the number of response choices available. In this
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study a single item with a 10-point scale was used. Respondents were instructed to indicate
their sleepiness at that moment by choosing a number between 1 (not sleepy at all) and 10
(very sleepy). Others have found that using a single item to measure sleep quality produces
reproducible and valid data in other patient groups (Cappelleri, et al 2009). No prior testing
of sensitivity and specificity of this approach was located. In this study, a cut-point of 4
(sleepy ≥ 4 or not sleepy < 4) was tested for sensitivity and specificity.
Analysis
Demographic and clinical characteristics are described using mean values and standard
deviations for continuous variables, and frequencies and percents for categorical variables.
Characteristics of the sample were compared according to dichotomized PSQI daytime
dysfunction subscale score (< 2 versus ≥ 2) using two-sample t-tests and chi-square statistics
for continuous and categorical variables, respectively. Linear regression models and Pearson
correlation coefficients were used to quantify the direction and strength of linear association
between PSQI daytime dysfunction subscale score and self-rated measures of daytime
sleepiness (ESS, SSS, and Likert item).
For each of the three self-rated daytime sleepiness measures, receiver operating
characteristic (ROC) curves were generated by plotting the sensitivity against 1-specificity.
The area under the ROC curve (AUC) was calculated to assess the accuracy of each measure
against the dichotomized PSQI daytime dysfunction subscale score. AUC measures the
ability of a screening tool to correctly classify individuals as having a specific condition or
not, in this case excessive daytime sleepiness. Scores can range from 0.5 to 1.0, where 0.5
indicates an uninformative screen, and 1.0 indicates a perfect screen. The predictive capacity
of the three subjective rating scales to predict the PSQI daytime dysfunction subscale score
was further described by estimating the sensitivity, specificity, positive predictive value,
negative predictive value, positive likelihood ratio (+LR), and negative likelihood ratio
(−LR), along with their corresponding 95% confidence intervals. Likelihood ratios can be
used to determine the odds of a specific outcome in a particular patient.
Results
Descriptive statistics were used to identify the predominant characteristics of the sample.
The sample of 280 was predominantly male (64%), Caucasian (63%), married (81%), older
adults (62 ±12.5 years) (Table 1). Most had systolic (69%) HF of ischemic origin (37%) and
were severely limited in their functional abilities (77% NYHA class III or IV). However,
comorbidity measured with the Charlson index (Charlson, Pompei, Ales, & MacKenzie,
1987) was low for most (53%), indicating that overall the subjects had few other major
illnesses.
When scores on the PSQI daytime dysfunction subscale were dichotomized at ≥ 2, only 16%
(n=45) of the sample reported significant daytime dysfunction due to poor sleep quality
(Table 1). Using t-tests and chi-square statistics, we found that those reporting daytime
dysfunction were likely to be younger (p<0.001), to be unmarried (p=0.002), to have New
York Heart Association (NYHA) functional class IV HF (p=0.015), and to report low
income (p=0.006) and fewer hours of sleep (p=0.015).
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The correlation between the three measures of daytime sleepiness was generally low (.24–.
41), with the exception of the relationship between the SSS and the Likert item, which was
moderately large with r=0.64 (Table 2). None of the three measures was moderately or
highly correlated with daytime dysfunction.
Using ROC curves, the measure of daytime sleepiness that was most sensitive to daytime
dysfunction was the Likert item (Table 3). Although sensitivity of the ESS was higher using
a cut-point of ≥ 6, specificity at this cut-point was low. At the cut-point of ≥ 11, the ESS was
moderately specific but inadequate in sensitivity. A similar picture was seen with the SSS.
Only the Likert item demonstrated adequate sensitivity and specificity.
Discussion
The results of this study suggest that use of a single scaled question about sleepiness is an
effective method of detecting sleep problems that may require further screening in a clinical
setting. These findings are important because abnormal sleep patterns are associated with
increased risks of morbidity, poor quality of life, and mortality (Zisapel, 2007). Daytime
sleepiness is an indicator of the need for further screening for SDB, as well as other chronic
conditions such as non-dipping hypertension (Erden et al., 2010), chronic kidney disease
(Kumar et al., 2010), depression (Koutsourelakis et al., 2009), and rheumatic disease
(Goodchild, Treharne, Booth, & Bowman, 2010). Adding this single scaled question to the
routine history may improve the detection of chronic comorbid conditions in adults with HF.
This study is the first to definitively show that neither the Stanford Sleepiness Scale nor the
Epworth Sleepiness Scale—regardless of the cut-point used—is sufficiently sensitive and
specific for use in clinical practice. In research, a single item measure of daytime sleepiness
is not adequate, but in clinical practice it may be the most practical and sensitive method for
screening (Schumacher, Gleason, Holloman, McLeod, 2010).
The Stanford Sleepiness Scale has fallen out of favor in recent years, probably because it
was suspected of poor sensitivity (Herscovitch & Broughton, 1981). The Epworth
Sleepiness Scale, however, is considered the gold standard for the assessment of daytime
sleepiness by many. In spite of this, the cut-point of ≥ 11 has been questioned by clinicians.
Even the instrument author recommends that the cut-point be modified for patients with HF.
In this population of adults with HF we found that only 16% reported daytime dysfunction
due to poor sleep quality. This was surprising, as sleep complaints are highly prevalent in
other populations. In a survey of 1,935 patients from family practice offices in North
Carolina, more than half the patients reported daytime sleepiness (Alattar, Harrington,
Mitchell, & Sloane, 2007). In that survey, one group likely to report poor sleep was those
with limited activity, similar to our sample of NYHA functional class III patients. The
reason that so few of our patients reported daytime dysfunction may be related to the known
change in sensitivity to impaired sleep that occurs with age (Bixler, Vgontzas, Ten Have,
Tyson, & Kales, 1998). Or, it could be related to the gray and white matter losses in the
brain that occur in HF (Woo, Kumar, Macey, Fonarow, & Harper, 2009).
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These results support those of prior investigators who have demonstrated that excessive
daytime sleepiness is not easily detected in adults with HF, even when they have SDB (Arzt
et al., 2006; Javaheri, et al., 1998; Johansson et al., 2010; Kaneko, et al., 2003; Rao et al.,
2006). In our study, daytime sleepiness did not differ in subjects with and without SDB. The
mean scores on the Epworth Sleepiness Scale in our sample were basically identical to those
found by Arzt et al (Arzt, et al., 2006) in their study of daytime sleepiness in patients with
HF. Comparing sleepiness in patients with and without HF, Arzt et al also concluded that
HF patients have less subjective daytime sleepiness than would be expected given the
prevalence of SDB. Clearly, a high level of suspicion needs to be used when considering
which patients to refer for further testing.
The sociodemographic factors characterizing patients with daytime dysfunction due to poor
sleep were age, marital status, and income. Sleep complaints are usually attributed to the
elderly (Stores, 2007), although others have found sleep problems to be more common in
younger individuals, as we found (Kumar, et al., 2010). The finding that single individuals
had more daytime dysfunction supports that of Hawkley and colleagues who found that
loneliness in socially isolated individuals predicted daytime dysfunction, independent of
sleep duration and after adjusting for depression (Hawkley, Preacher, & Cacioppo, 2010).
Our finding that individuals with lower income were more likely to report more daytime
dysfunction supports results from the 2004–2007 National Health Interview Survey. Lower
income was found to be associated with poor sleep in that nationally representative survey
of 110,441 noninstitutionalized US adults (Krueger & Friedman, 2009).
One limitation of this study is that the sample of adults with HF may not mirror that of the
general population of HF patients, who are generally older. These patients were younger
probably because everyone with HF was included, regardless of the type or etiology of HF
(systolic or diastolic). This decision influenced the mean age of the sample but may also
have made the results more generalizable to HF patients overall.
Implications for Practice
The likelihood ratios in Table 3 can be used to identify the odds of daytime dysfunction
associated with daytime sleepiness in a particular patient. The positive likelihood ratio of
2.37 for the Likert item indicates that the likelihood of having daytime dysfunction for a
patient scoring 4 or more on that single item has increased by approximately 2.4-fold over
someone with a score less than 4. These results suggest that a higher index of suspicion is
warranted in HF patients who are relatively young, unmarried, functionally compromised,
those with low income and an inadequate amount of sleep. Those reporting sleepiness
should be considered for further screening.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
ROC curve for Predicting Sleep Dysfunction (Score ≥ 2)
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Table 2
Correlation coefficients among PSQI Sleep Dysfunction Score and Measures of Sleepiness
PSQI Sleep Dysfunction Score Stanford Sleepiness Scale Epworth Sleepiness Scale
Stanford Sleepiness Scale 0.40
Epworth Sleepiness Scale 0.40 0.24
Likert-type rating scale 0.41 0.64 0.29
PSQI = Pittsburgh Sleep Quality Index
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